PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
GLP-1s, Thiamine, and Wernicke’s Encephalopathy
GLP1 AgonistsMed-PsychResearchResearch for the PublicSide Effects

GLP-1s, Thiamine, and Wernicke’s Encephalopathy

September 2, 2026by Chris Aiken, MD1
More on the GLP1-Lithium Interaction
GLP1 AgonistsLithiumMedicationsResearch

More on the GLP1-Lithium Interaction

August 3, 2026by Chris Aiken, MD0
Oral Ozempic Delivers Mixed Results on Alcohol Use
AlcoholGLP1 AgonistsMedicationsResearchSubstance Use

Oral Ozempic Delivers Mixed Results on Alcohol Use

July 29, 2026by Chris Aiken, MD0
Best Add-On Drugs for Antipsychotic Weight Gain
AntipsychoticsDisordersMedicationsResearchSchizophrenia and PsychosisSide Effects

Best Add-On Drugs for Antipsychotic Weight Gain

July 10, 2026by Chris Aiken, MD0
Can GLP-1s Both Cause and Prevent Pancreatitis?
AlcoholGLP1 AgonistsMed-PsychResearchResearch for the PublicSide EffectsTop Research

Can GLP-1s Both Cause and Prevent Pancreatitis?

June 15, 2026by Chris Aiken, MD1
A Lithium GLP-1 Interaction
BipolarBipolar MedsGLP1 AgonistsLithiumResearchSide Effects

A Lithium GLP-1 Interaction

June 8, 2026by Chris Aiken, MD0
GLP-1 Drugs and Opioid Use Disorder
GLP1 AgonistsOpioidsResearchSubstance Use

GLP-1 Drugs and Opioid Use Disorder

May 13, 2026by Chris Aiken, MD0
A GLP-1 Trial Changes the Score in Alcohol, With a Catch
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop Research

A GLP-1 Trial Changes the Score in Alcohol, With a Catch

May 5, 2026by Chris Aiken, MD0
Semaglutide May Improve Persistence in Depression
DepressionGLP1 AgonistsResearch

Semaglutide May Improve Persistence in Depression

May 1, 2026by Chris Aiken, MD0
GLP-1 Agonists Improve Well-being, But Not Depression
DepressionGLP1 AgonistsMedicationsResearchResearch for the Public

GLP-1 Agonists Improve Well-being, But Not Depression

April 2, 2026by Chris Aiken, MD0
GLP-1s May Prevent Mental Illness
GLP1 AgonistsResearch

GLP-1s May Prevent Mental Illness

March 21, 2026by Chris Aiken, MD0
Semaglutide for Antipsychotic Weight Gain
AntipsychoticsMedicationsResearchSchizophrenia and PsychosisSide Effects

Semaglutide for Antipsychotic Weight Gain

March 4, 2026by Chris Aiken, MD0
Semaglutide (Ozempic) in Depression
CognitionDepressionGLP1 AgonistsResearchResearch for the PublicTop Research

Semaglutide (Ozempic) in Depression

December 5, 2025by Chris Aiken, MD0
Ozempic for Alcohol Use Disorder
AlcoholMedicationsSubstance UseTop Research

Ozempic for Alcohol Use Disorder

April 1, 2025by Chris Aiken, MD0
Top Studies
All Studies
Self Help
Become a Therapy Partner

Recent Posts

  • October 2, 2026Benzodiazepine Prescriptions Decline in US

  • October 2, 2026Cognitive Impairment in Substance Use Disorders

  • October 2, 2026Adderall Ineffective for Cognitive Problems in MS

  • October 2, 2026Top Meds for Mixed Depression

  • October 1, 2026Perimenopause and Bipolar Disorder

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Uncategorized
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image